These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38722794)

  • 1. Structural and Computational Insights into Dynamics and Intermediate States of Orexin 2 Receptor Signaling.
    Yokoi S; Suno R; Mitsutake A
    J Phys Chem B; 2024 Jun; 128(25):6082-6096. PubMed ID: 38722794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics Simulations for the Determination of the Characteristic Structural Differences between Inactive and Active States of Wild Type and Mutants of the Orexin2 Receptor.
    Yokoi S; Mitsutake A
    J Phys Chem B; 2021 May; 125(17):4286-4298. PubMed ID: 33885321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based development of a subtype-selective orexin 1 receptor antagonist.
    Hellmann J; Drabek M; Yin J; Gunera J; Pröll T; Kraus F; Langmead CJ; Hübner H; Weikert D; Kolb P; Rosenbaum DM; Gmeiner P
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18059-18067. PubMed ID: 32669442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic structural difference between inactive and active states of orexin 2 receptor determined using molecular dynamics simulations.
    Yokoi S; Mitsutake A
    Biophys Rev; 2022 Feb; 14(1):221-231. PubMed ID: 35340605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
    Suno R; Kimura KT; Nakane T; Yamashita K; Wang J; Fujiwara T; Yamanaka Y; Im D; Horita S; Tsujimoto H; Tawaramoto MS; Hirokawa T; Nango E; Tono K; Kameshima T; Hatsui T; Joti Y; Yabashi M; Shimamoto K; Yamamoto M; Rosenbaum DM; Iwata S; Shimamura T; Kobayashi T
    Structure; 2018 Jan; 26(1):7-19.e5. PubMed ID: 29225076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation.
    Hong C; Byrne NJ; Zamlynny B; Tummala S; Xiao L; Shipman JM; Partridge AT; Minnick C; Breslin MJ; Rudd MT; Stachel SJ; Rada VL; Kern JC; Armacost KA; Hollingsworth SA; O'Brien JA; Hall DL; McDonald TP; Strickland C; Brooun A; Soisson SM; Hollenstein K
    Nat Commun; 2021 Feb; 12(1):815. PubMed ID: 33547286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
    Yin J; Mobarec JC; Kolb P; Rosenbaum DM
    Nature; 2015 Mar; 519(7542):247-50. PubMed ID: 25533960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
    Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Orexin Receptor Binding and Activation-A Molecular Dynamics Study.
    Karhu L; Magarkar A; Bunker A; Xhaard H
    J Phys Chem B; 2019 Mar; 123(12):2609-2622. PubMed ID: 30786708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel in the Activation Mechanism of the Type I Cannabinoid Receptor.
    Sarkar A; Mitra A; Borics A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
    Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
    Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction modes of human orexin 2 receptor with selective and nonselective antagonists studied by NMR spectroscopy.
    Imamura K; Akagi KI; Miyanoiri Y; Tsujimoto H; Hirokawa T; Ashida H; Murakami K; Inoue A; Suno R; Ikegami T; Sekiyama N; Iwata S; Kobayashi T; Tochio H
    Structure; 2024 Mar; 32(3):352-361.e5. PubMed ID: 38194963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminus of OX2R significantly affects downstream signaling pathways.
    Wang C; Xu C; Liu M; Pan Y; Bai B; Chen J
    Mol Med Rep; 2017 Jul; 16(1):159-166. PubMed ID: 28487995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.
    Torrens-Fontanals M; Stepniewski TM; Aranda-García D; Morales-Pastor A; Medel-Lacruz B; Selent J
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying multiple active conformations in the G protein-coupled receptor activation landscape using computational methods.
    Dong SS; Goddard WA; Abrol R
    Methods Cell Biol; 2017; 142():173-186. PubMed ID: 28964335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor.
    Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L
    J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.
    Heifetz A; Barker O; Morris GB; Law RJ; Slack M; Biggin PC
    Biochemistry; 2013 Nov; 52(46):8246-60. PubMed ID: 24144388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
    Rappas M; Ali AAE; Bennett KA; Brown JD; Bucknell SJ; Congreve M; Cooke RM; Cseke G; de Graaf C; Doré AS; Errey JC; Jazayeri A; Marshall FH; Mason JS; Mould R; Patel JC; Tehan BG; Weir M; Christopher JA
    J Med Chem; 2020 Feb; 63(4):1528-1543. PubMed ID: 31860301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.